Live
Audio Only
The country is reporting 1,000 deaths per day as the Bolsonaro administration is being criticized for the slow vaccination campaign.
Brazil's National Health Surveillance Agency (ANVISA) on Tuesday allowed large-scale use of the Pfizer COVID-19 vaccine, although far-right-wing President Jair Bolsonaro's administration has not yet purchased the immunizer.
RELATED:
Brazilian Petrobras Plummets Following Bolsonaro's Criticism
"The vaccine developed by U.S. Pfizer and German BioNTech laboratories has proven safety, quality, and efficacy," ANVISA stated as it recalled that this is the first COVID-19 vaccine registered for widespread use in the Americas.
The drug regulator's authorization allows the vaccine's use for the entire population and its commercialization in the national market.
Pfizer vaccine's definitive approval occurs amid the second wave of contagions that has caused hospital collapse in states such as Amazonas and Roraima.
COVID 19 Update
— Mawangwa Ibrahim (@mawangwa) February 24, 2021
By close of yesterday,The world had recorded 112,637,975 cases of COVID 19 in total, USA leading with 28,897,718 cases arising from +71,054 new cases. Brazil with +63,090.
������������
New deaths
USA +2,404
Brazil +1,370
UK +548
Spain +443 pic.twitter.com/bjoTygE0Oa
Since the beginning of the year, the Health Ministry is reporting over 1,000 deaths per day as the Bolsonaro administration is being criticized for the country's slow vaccination campaign.
Brazil, which is the second hardest-hit country by the pandemic, has only vaccinated 2 percent of its 212 million population.
Health authorities kicked off the campaign with the Chinese CoronaVac vaccine and the AstraZeneca vaccine.
#Brazil | Brazilians protest against Bolsonaro over the health crisis in Amazonas state. pic.twitter.com/WVLjytLhqX
— teleSUR English (@telesurenglish) January 16, 2021
Newsletter
